O2h Ventures — Full Portfolio
8 tracked investments · listed companies and verified rows first
Exonate is a biotechnology company developing treatments for retinal vascular diseases, with a lead asset (EXN407) intended as a topical therapy for diabetic retinopathy and diabetic macular oedema.
BiotechDigital HealthHealthtechMedical Devices
Olav Hellebø(Chief Executive Officer)
Co-investorsWellcome TrustWren CapitalCambridge Angels groupEMV CapitalMartlet CapitalStoic VC+1 more
Atelerix develops hypothermic hydrogel encapsulation technology that stabilises and preserves fresh cells, tissues, and blood at room temperature, eliminating the need for cryopreservation and cold-chain logistics.
BiotechMedical DevicesNew Materials
Co-investorsCambridge Angels groupFuture Planet CapitalUK Innovation & Science Seed Fund
Enedra analyzes tumor evolution patterns by decoding convergent genomic signatures from cancer genomic data.
AI & Machine LearningBiotechMedical Devices
Co-investorsDeep Science VenturesKU Leuven Research & Development
The Financial Ombudsman Service is a free UK public body, established by Parliament in 2001, that investigates complaints about financial businesses such as banks, insurers, pension and investment providers, and claims management companies.
FintechGovTech
Co-investorsDeepbridge CapitalForce Over Mass CapitalFuel VenturesOxfordQVenturesSeneca Partners+1 more
BiotechDundee, Scotland
Timothy Jason Sparey(Executive Officer)Antoine Boulanger(Executive Officer)Francisca Peixoto(Executive Officer)Christopher Andrew Woodland(Executive Officer, Director)Mary Canning(Executive Officer)
Helus Pharma is a clinical-stage biopharmaceutical company developing small-molecule therapies for psychiatric and CNS conditions such as depression, anxiety, schizophrenia, and bipolar disorder.
BiotechHealthtechMental Health
Eric So(Co-Founder, Executive Chairman)John Kanakis(Co-Founder)Paul Glavine(Co-Founder and Chief Growth Officer)Michael Halstead(Chief Executive Officer)Michael Cola(Chief Executive Officer)Aaron Bartlone(Chief Operating Officer)
London
Carol Routledge(Executive Officer)George Tziras(Director)Khalid Howladar(Director)Marie Claire Layzell(Executive Officer, Director)Peter Rands(Executive Officer, Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.